Skip Nav Destination
Issues
January 2022
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 2296-9403
EISSN 2296-9365
In this Issue
Inflammatory Intestinal Diseases 2022, Vol. 7, No. 1
Prelims
Title Page/Table of Contents
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 1–4.
https://doi.org/10.1159/000521666
Editorial
Editorial
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 5–6.
https://doi.org/10.1159/000520489
Review Article
Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication?
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 7–12.
https://doi.org/10.1159/000518131
Early Laparoscopic Ileal Resection for Localized Ileocecal Crohn’s Disease: Hard Sell or a Revolutionary New Norm?
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 13–20.
https://doi.org/10.1159/000515959
Surgical Techniques and Risk of Postoperative Recurrence in CD: A Game Changer?
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 21–27.
https://doi.org/10.1159/000515372
5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 28–35.
https://doi.org/10.1159/000518865
Mucosal Healing in Crohn’s Disease: Bull’s Eye or Bust? “The Pro Position”
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 36–41.
https://doi.org/10.1159/000519521
Mucosal Healing in Crohn’s Disease: Bull’s Eye or Bust? The “Relative” Con Position
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 42–49.
https://doi.org/10.1159/000519731
Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 50–58.
https://doi.org/10.1159/000518755
Stopping Anti-TNF in CD Remitters: Cons
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 59–63.
https://doi.org/10.1159/000517961
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 64–68.
https://doi.org/10.1159/000520942
Author Index Vol. 7, No. 1, 2022
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 69.
https://doi.org/10.1159/000521667
Subject Index Vol. 7, No. 1, 2022
Subject Area:
Gastroenterology
Inflamm Intest Dis (2022) 7 (1): 70.
https://doi.org/10.1159/000521668